期刊文献+

树突状细胞和肿瘤免疫治疗研究进展 被引量:2

下载PDF
导出
作者 周娟 徐立春
出处 《实用肿瘤学杂志》 CAS 2006年第2期146-150,共5页 Practical Oncology Journal
  • 相关文献

参考文献25

  • 1Chordhury BA,Liang JC,Thomas EK,et al.Dendritic cells derived in vitro from acute myelogenous leukemia cellsstimulate autologous antileukemic T-cellresponse[J].Blood,1999;93:780
  • 2Chen BB,Shi Y,Smith JD,et al.The role of tumor necrosis factor ain modulating the quantity of peripheral blood-drived,cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell funtion in presenting soluble antigen to CD + T cells in vitro[J].Blood,1998;91(12):4652 ~ 4661
  • 3Ludeuig B,Graf D,Gelderblom HR,et al.Spontancous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD4-ligand) and TNF-α,but strongly enhanced by interleukin-10[J].E ur J Immunol,1995;25:1943
  • 4Chapuis F,Rosenzwaig M,Yagello M,e al.Differentiation of human dendritic cells from moncytes in vitro[J].Eur J Immunol,1997; 27:431
  • 5Caux C,Vanbervliet B,Massacrier C,et al.CD34 + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+ TNF-α[J].J Exp Med,1996;184:695
  • 6Bancherv J,Steinman RM.Dendritic cell and the control of immunity[J].Nature,1998;245:392
  • 7Norbury CC,Chambers BJ,Prescott AR,et al.Constitutive macropincytosis allows TAP-dependent major histocompatibility complex class Ⅰ presentation of exogenous solubleantigen by bone marrow-derived dendriticcells[J].Eur J Immunol,1997;27(1):280
  • 8Adema GJ,Hartgers F,Verstraten R,et al.A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells[J].Nature,1997;387:713
  • 9Lu L,Qian S,Hershberger PA,et al.Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation[J].J Immunol,1997; 158(12):5675
  • 10Albert ML,Sauter B,Bhardwaj N.Dendritic cells acquire antigen from apoptotic cells and induce class Ⅰ-restricted CTLs[J].Nature,1998; 392:862

二级参考文献14

共引文献70

同被引文献20

  • 1黄海林,王为民.CD4+CD25+T调节性细胞与肿瘤[J].实用肿瘤学杂志,2006,20(1):65-68. 被引量:4
  • 2程志祥,刘宝瑞.Th1/Th2漂移与肿瘤免疫治疗[J].江苏医药,2006,32(6):567-568. 被引量:12
  • 3黄华健,朱建军.恶性肿瘤T细胞亚群检测的临床意义探讨[J].医学临床研究,2006,23(7):1043-1044. 被引量:13
  • 4张双民,吴忠道.树突状细胞疫苗治疗肿瘤的实验研究进展[J].热带医学杂志,2006,6(11):1230-1233. 被引量:4
  • 5Liu SH, Zhang M, Zhang WG, et al. Strategies of antigen specific T-cell-based immunotherapy for cancer. Cancer Biother Radiopharm,2005, 20(5) :491.
  • 6金栾.安慰效应在症状处置中的作用[J].国外医学:护理学分册,1998,17(3):140-140.
  • 7Radzikowska E, Roszkowski K. Lung cancer - diagnosis and therapy delay [ J ]. Pnneumonol Alergol Pol, 2001,69 ( 11 ) : 600 -610.
  • 8Davies JA. Do different branching epithelia use a conserved developmental mechanism [ J ]. Bio Essays, 2002,24 ( 10 ) : 937 - 948.
  • 9Deepak P, Assudani RB, Roger B, et al. The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines [ J ]. Cancer Immunol Immunother,2007,56 (1) :70 -80.
  • 10Jeon HS, Jen J. TGF - β signaling and the role of inhibitory smads in Non - small cell lung cancer[J]. Journal of Tho- racic Oncology,2010,5 (4) :417 - 419.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部